Pharmaceuticals
Biopharmaceutical
Cancer
Unitedstates
Development
Therapeutics
M&A Advisory
Lazard
Full Credential Description
Cyclacel Pharmaceuticals. United States. Announced Date 13/02/2007. Closed Date 13/02/2007. Deal value: $36m. Registered direct offering of common stock. Industry: Cyclacel Pharmaceuticals is a biopharmaceutical company focused on developing cancer therapeutics.